ADVICENNE
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.
ADVICENNE
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Nîmes, Languedoc-Roussillon, France
Country:
France
Website Url:
http://www.advicenne.com
Total Employee:
11+
Status:
Active
Contact:
+33619202950
Email Addresses:
[email protected]
Total Funding:
25.4 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Investors List
IRDI
IRDI investment in Venture Round - Advicenne
InnoBio Fund
InnoBio Fund investment in Venture Round - Advicenne
IXO Private Equity
IXO Private Equity investment in Venture Round - Advicenne
MI Care
MI Care investment in Venture Round - Advicenne
Cemag Invest
Cemag Invest investment in Venture Round - Advicenne
Official Site Inspections
http://www.advicenne.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.17 K
- Host name: cluster026.hosting.cdn.ovh.net
- IP address: 46.105.204.26
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
